Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sepsis × telavancin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Staphylococcal Infections 1 Sepsis 1 Infections 1 Bacteremia 1

Interventions

telavancin 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Alkaline Phosphatase 1 Acupuncture Therapy 1 2-Propanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01321879 2019-12-27

Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Completed

40 enrolled 6 charts

Infections, Staphylococcal Infections, Bacteremia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡